Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: Is serum hyaluronan a potential predictor?

Aesthetic Plastic Surgery

Volumn 29, Issue 6, 2005, Pages 510-518

  Prantl, L ^a,b   Poppl N ^a   Horvat, N ^a   Heine, N ^a   Eisenmann Klein, M ^a  

^a University of Regensburg ^*

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Capsular contracture; Composition of fibrous capsule; Local T cell immune response; Serum fibrosis indexes; Serum hyaluronan

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; BREAST AUGMENTATION; CAPSULAR CONTRACTURE; CELL SUBPOPULATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTRACTURE; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FIBROBLAST; FIBROSIS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MAST CELL; PLASMA CELL; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; SILICONE PROSTHESIS;

ADULT; BREAST; BREAST IMPLANTS; CONTRACTURE; FEMALE; HUMANS; HYALURONIC ACID; MAMMAPLASTY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; SILICONE GELS; T-LYMPHOCYTES;

EID: 29744440172     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-005-5049-y     Document Type: Article

References (56)

1. Alfano C, Mazzocchi M, Scuderi N: Mammary compliance: An objective measurement of capsular contracture. Aesth Plast Surg 28:75-79, 2004
2. Baker JL Jr, Chandler ML, LeVier RR: Occurrence and activity of myofibroblasts in human capsular tissue surrounding mammary implants. Plast Reconstr Surg 68:905, 1981
3. Baran CN, Peker F, Ortak T, Sensoz O, Baran NK: A different strategy in the surgical treatment of capsular contracture: Leave capsule intact. Aesth Plast Surg 25:427-431, 2001
4. Beekman WH, Hage JJ, Jorna LB, Mulder JW: Augmentation mammaplasty: The story before the silicone bag prosthesis. Ann Plast Surg 43:446-451, 1999
5. Brody GS: On the safety of breast implants. Plast Reconstr Surg 100:1314-1321, 1997
6. Brown SL, Pennello G, Berg WA, Soo MS, Middleton MS: Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol 28:996-1003, 2001
7. Brunmark A, O'Rourke AM: Augmentation of mature CD44 cell response to isolated antigenic class II proteins by fibronectin and intercellular cell adhesion molecule-1. J Immunol 159:1676-1685, 1997
8. Burckhardt BR: Capsular contracture: Hard breasts, soft data. Clin Plast Surg 15:521, 1988
9. Camirand A, Doucet J: Breast augmentation: Teaching our patients how compression can help prevent capsular contracture. Aesth Plast Surg 24:221-226, 2000
10. Chiquet M: Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol 18:417-426, 1999
11. Cimons M: FDA plans safety reviews of several medical devices. Los Angeles Times, April 28, 1992, A-14
12. Cunningham B: Update on situation of breast implants in the U.S. Presented at EQUAM's 3rd Consensus Conference, Regensburg, Germany, 1998
13. Deapen DM, Bestein L, Brody GS: Are breast implants anticarcinogenic? A 14-year-follow-up of the Los Angeles Study. Plast Reconst Surg 5:1346-1353, 1997
14. Dolores W, Rainer C, Niederegger H, Piza H, Wick G: Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmunity 23:81-91, 2004
15. Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL: A review of the literature on the aetiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesth Plast Surg 23:197-206, 1999
16. European Commission: Guidelines for conformity assessment of breast implants according to directive, 93/42/EEC relating to medical devices. European Commission. Directorate - General III Industry, Brussels, July 1998
17. Frangou J, Kanellaki M: The effect of local application of mitomycin-C on the development of capsule around silicone implants in the breast: An experimental study in mice. Aesth Plast Surg 25:118-128, 2001
18. Gabriel SE, et al.: Complications leading to surgery after breast implantation. N Engl J Med 336:677-682, 1997
19. Gerszten PC: A formal risk assessment of silicone breast implants. Biomaterial 20:1063-1069, 1999
20. Grigg M, Bondurand S, Ernster VL, Herdman R: Information for women about the safety of silicone breast implants. Report of the Institute of Medicine, Washington DC, June 1999
21. Gylbert L, Asplund O, Jurell G: Capsular contracture after breast reconstruction with silicone- and saline-filled implants: A 6-year follow-up. Plast Reconstr Surg 86:809-811, 1990
22. Heppleston AG, Styles JA, cited by Carr I: The macrophage. Academic Press: London, 1973,84
23. Karlson EW, Hankinson SE, Liang MH, Sanchez-Guerrero J, Colditz GA, Rosenau BJ, et al.: Association of silicone breast implants with immunologic abnormalities: A prospective study. Am J Med 106:11-19, 1999
24. Knudson W: The role of CD44 as a cell surface hyaluronan receptor during tumor invasion and metastasis. Frontiers Biosci 3:604-615, 1998
25. Kumari K, Weigel PH: Molecular cloning, expression, and characterization of the authentic hyaluronan synthase form group C Streptococcus equisimilis. J Biol Chem 272:32539-32546, 1997
26. Lossing C, Hansson H-A: Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast Reconstr Surg 91:1277, 1993
27. Markovitz M, Cifonelli JA, Dorfman A: The biosynthesis of hyaluronic acid by group A streptococcus: VI. Biosynthesis from uridine nucleotides in cell-free extracts. J Biol Chem 234:2342-2350, 1959
28. Martin-Moreno J, Gorgojo L, Gonzales J, Wiesbaum W: Draft final report study: Health Risk Posed by Silicone Implants in General With a Special Attention to Breast Implants. European Commission Directorate General III Industry, Brussels, March 2000
29. Maxwell GP, Lugston PA: Management of complications following augmentation mammaplasty. In: Georgeade GS, Riefkohl R, Levin LS (eds). Georgeade plastic, maxillofacial and reconstructive surgery. 3rd ed. Williams & Wilkins, Baltimore, MD, 1997
30. Meyer K, Palmer JW: The polysaccharide of the vitreous humor. J Biol Chem 107:629-634, 1934
31. Neudecker BA, Stern R, Connolly MK: Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Br J Dermatol 150:469-476, 2004
32. Olivari N: Infection and capsular fibrosis. ISAPS 2004 postgraduate course, Berlin, March 2004
33. Perschl A, Lesley J, English N, Trowbridge I, Hyman R: Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 25:495-501, 1995
34. Peters WJ, Smith D, Lugowsky S: Failure properties of 352 explanted silicone implants: A report of 300 patients. Ann Plast Surg 34:3-6, 1995
35. Planas J, Cervelli V, Planas G: Five-year experience on ultrasonic treatment of breast contractures. Aesth Plast Surg 25:89-93, 2001
36. Puckett CL: On the safety of silicone gel implants. Cancer Invest 18:278-280, 2000
37. Rosenbaum D, Peric S, Holecek M, Ward HE: Hyaluronan in radiation-induced lung disease in the rat. Radiat Res 147:585, 1997
38. Schmits R, et al.: CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90:2217-2223, 1997
39. Scott JE: Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues. FASEB J 6:2639-2645, 1992
40. Sergott TJ, Limoli JP, Baldwin CM, Laub DR: human adjuvant disease, possible autoimmune disease after silicone implantation. Plast Reconstr Surg 78:104-111, 1986
41. Siggelkow W, Faridi A, Spiritus K, et al.: Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials 24:1101, 2003
42. Sundstrom G, Lofvenberg E, Hassan I, Engstrom-Laurent A: Localisation and distribution of hyaluronan in normal bone marrow matrix: A novel method to evaluate impending fibrosis? Eur J Haematol 68:194, 2002
43. Takayanagi S, Nakagawa C, Sugimoto Y: Augmentation mammaplasty: Where should the implant be placed? Aesth Plast Surg 28:83-88, 2004
44. Tao J, Peng HQ, Cai WM, Dong FQ, Weng HL, Liu RH: Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol 9:2497-2500, 2003
45. Tenenbaum SA, Rice JC, Espinoza LR, Cuèllar ML, Plymale DR, Sander DM, et al.: Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 349:449-454, 1997
46. Tugwell P, Wells G, Peterson J, Welch V, Page J, Davison C, et al.: Do silicone breast implants cause rheumatologic disorders? A systemic review for a court-appointed national science panel. Arthritis Rheum 44:2477-2484, 2001
47. Tuhkanen A-L, Tammi M, Tammi R: CD44 substituted with heparan sulfate and endo-beta-galactosidase-sensitive oligosaccharides: A major proteoglycan in adult human epidermis. J Invest Dermatol 109:213-218, 1997
48. Ulrich D, Noah EM, Burchardt ER, Atkins D, Pallua N: Serum concentration of aminoterminal propeptide of type III procollagen (PIIINP) as a prognostic marker of skin fibrosis after scar correction in burned patients. Burns 28:766, 2002
49. Ulrich D, Noah EM, von Heimburg D, Pallua N: TIMP-1, MMP-2, -9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg 111:1423, 2003
50. Vasquez B, Given KS, Housten GC: Breast augmentation: Review of subglandular and submascular implantation. Aesth Plast Surg 11:101-105, 1987
51. Weissmann B, Meyer K: The structure of hyalobiuronic acid and of hyaluronic acid from umbilical cord. J Am Chem Soc 76:1753-1757, 1954
52. Wells AF, Daniels S, Gunasekaran S, Wells KE: Local increase in hyaluronic acid and interleukin-2 in the capsules surrounding silicone breast implants. Ann Plast Surg 33:1-5, 1994
53. Wick G, Wagner R, Klima G, Wilfingseder P: Immunohistochemical analysis of the connective tissue capsule formation and constriction around mammary silicone prostheses. In: Kano K, Mori S, Sugisaki T, Torisu M (ed) cellular, molecular, and genetic approaches to immunodiagnosis and immunotherapy. University of Tokyo Press pp 231-241,1987
54. Wyatt HA, Dhawan A, Cheeseman P, Mieli-Vergani G, Price JF: Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease. Arch Dis Child 86:190-193, 2002
55. Wyatt Lance E, Sinow J, Wollman JS, Sami DABS, Miller TA: The influence of time on human breast capsule histology: Smooth and textured silicone-surfaced implants. Plast Reconstr Surg 102:1922-1931, 1998
56. Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL: Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int 2:69-72, 2003